Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Recs

10
Player Avatar Swizzled (< 20) Submitted: 5/31/2006 12:44:43 AM : Outperform Start Price: $47.14 JNJ Score: +59.81


It's all I can do to not put all of my money into JNJ and go nap on the couch for 25 years. Balance sheet superior. History of EPS increases superior. Industry, right where I want to be with an aging population. Trading below market multiple and paying a nice dividend. I hope it stays under $60 for a year and I'll just keep buying.

Featured Broker Partners


Advertisement